Lv21
140 积分 2024-12-04 加入
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
1个月前
已完结
Risk of HBV reactivation during therapies for HCC: A systematic review
3个月前
已完结
Notice of Retraction and Replacement. Choi et al. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a Korean nationwide cohort study. JAMA Oncol. 2019;5(1):30-36
5个月前
已完结
Asia-Pacific Modified Delphi Consensus Conference on Large Hepatocellular Carcinoma
8个月前
已关闭
Analysis of a Modified Surgical Desirability of Outcome Ranking (mDOOR) Among Patients Undergoing Surgery for Hepatocellular Carcinoma
8个月前
已完结
Standardized comparison of open versus minimally invasive surgery in patients undergoing hepatectomy through the Textbook Outcome
9个月前
已关闭
Efficacy and safety of radiotherapy combined with immune checkpoint inhibitors for advanced or unresectable hepatocellular carcinoma: a systematic review and meta-analysis
9个月前
已完结
Combination locoregional and systemic therapies in hepatocellular carcinoma
9个月前
已完结
Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial
9个月前
已完结
皖公网安备34019202002308
